Document is current
Any future updates will be listed below
-
Authors
Lan, Xin
Huang, Wei http://orcid.org/0000-0003-2097-8148
Kim, Su Bin http://orcid.org/0000-0003-1867-6829
Fu, Dechen
Abeywansha, Thilini http://orcid.org/0000-0002-2831-9852
Lou, Jiemin
Balamurugan, Udayakumaran
Kwon, Yong Tae http://orcid.org/0000-0002-8115-3150
Ji, Chang Hoon http://orcid.org/0000-0002-1315-838X
Taylor, Derek J. http://orcid.org/0000-0001-9932-1856
Zhang, Yi http://orcid.org/0000-0001-8170-9983
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM150678, GM142002)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA241301, CA240993)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Ministry of Science, ICT and Future Planning (NRF-2020R1A5A1019023, NRF-2021R1A2B5B03002614, RS-2023-00249464)
- License Information
-
More Information
Article History
Received: 29 October 2023
Accepted: 18 July 2024
First Online: 28 July 2024
Competing interests
: W.H. and D.J.T. provide consultation for, and D.J.T. has ownership interests in, Rappta Therapeutics, which focuses on areas of research unrelated to the present study. The remaining authors declare no competing interests.
